SINTX Technologies Hits New 52-Week Low at $1.66 Amid Ongoing Struggles

SINTX Technologies, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 1.66 on July 10, 2026. This significant decline reflects a challenging year for the company, which has seen its stock price plummet by 62.2% over the past year, contrasting sharply with the S&P 500's performance of 20.62% during the same period. The company's financial metrics indicate ongoing difficulties, with a negative return on equity of -349.61% and a debt-to-equity ratio of -1.28. SINTX has reported losses for five consecutive quarters, with net sales for the half-year at USD 0.67 million, down 26.45%. Additionally, the company's return on capital employed (ROCE) stands at a notably low -311.41%, and its inventory turnover ratio is just 1.12 times. Institutional investor participation has also waned, with a decrease of 1.89% in their stakes, now collectively holding 11.43% of the company. These factors contribute to a perception of increased risk surrounding SINTX Technologies, as it continues to struggle with both short-term and long-term performance metrics.